Spiro succinimide derivative in the treatment of dementia of the

Details Spiro succinimide derivative in the treatment of dementia of the Spiro succinimide derivative in the treatment of dementia of the

1983-06-20

1984-11-06

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Parasitic organism or component thereof or substance...

A61K 31445

Patent

active

044812060

ABSTRACT:
Spiro-(N'-methyl-piperidyl-4')-N-ethyl-succinimide for the treatment of Alzheimer's disease and senile dementia of the Alzheimer type.

REFERENCES:
patent: 3056796 (1962-10-01), Jucker et al.
Bubb et al., Proxis 55, 40, pp. 1144-1146 (1966).
Herz et al., Abstract, Arch. Exp. Pathol. Pharmacol. 253, No. 1, 46-47 (1966).
Costall et al., Neuropharmacology 13, No. 5, 353 (1974)-abstract.
Costall et al., J. Pharm. Pharmacol. 27, No. 4, 273 (1975)-abstract.
Costall et al., Psychopharmacologia 43, No. 1, 69 (1975)-abstract.
Kaakkola et al., Psychopharmacology 52, No. 1, 7 (1977)-abstract.
Perry, Alzheimer's Disease: Early Recognition of Potentially Reversible Deficits, 27, Ed. Glen & Whally, Churchill Livingstone: Edinburgh 1979.
Glen, Alzheimer's Disease, supra, p. 140.
Smart, Alzheimer's Disease, supra, p. 183.
Davis et al., Life Sciences 23, 1729 (1978).
Davies et al., Brain Research 138, 385 (1978).

Affiliated with

Also associated with

Rating

Spiro succinimide derivative in the treatment of dementia of the does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spiro succinimide derivative in the treatment of dementia of the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro succinimide derivative in the treatment of dementia of the will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1042082